Cargando…
Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEA...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861384/ https://www.ncbi.nlm.nih.gov/pubmed/28844992 http://dx.doi.org/10.1136/heartjnl-2017-311508 |
_version_ | 1783308081698963456 |
---|---|
author | Adamson, Philip D Hunter, Amanda Williams, Michelle C Shah, Anoop S V McAllister, David A Pawade, Tania A Dweck, Marc R Mills, Nicholas L Berry, Colin Boon, Nicholas A Clark, Elizabeth Flather, Marcus Forbes, John McLean, Scott Roditi, Giles van Beek, Edwin J R Timmis, Adam D Newby, David E |
author_facet | Adamson, Philip D Hunter, Amanda Williams, Michelle C Shah, Anoop S V McAllister, David A Pawade, Tania A Dweck, Marc R Mills, Nicholas L Berry, Colin Boon, Nicholas A Clark, Elizabeth Flather, Marcus Forbes, John McLean, Scott Roditi, Giles van Beek, Edwin J R Timmis, Adam D Newby, David E |
author_sort | Adamson, Philip D |
collection | PubMed |
description | OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4146 participants with suspected angina randomised to CTCA. Patients were dichotomised into NICE guideline-defined possible angina and non-anginal presentations. Primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and prognostic endpoint comprised fatal and non-fatal myocardial infarction (MI). RESULTS: In 3770 eligible participants, CTCA increased diagnostic certainty more in those with possible angina (relative risk (RR) 2.22 (95% CI 1.91 to 2.60), p<0.001) than those with non-anginal symptoms (RR 1.30 (1.11 to 1.53), p=0.002; p(interaction) <0.001). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (HR 0.32 (0.19 to 0.52), p<0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13 to 2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30 to 2.05), p=0.622). At 3.2 years of follow-up, fatal or non-fatal MI was reduced in patients with possible angina (3.2% to 1.9%%; HR 0.58 (0.34 to 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25 to 1.69), p=0.379). CONCLUSIONS: NICE-guided patient selection maximises the benefits of CTCA on diagnostic certainty, use of invasive coronary angiography and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA and increase the rates of invasive investigation. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT01149590;post results. |
format | Online Article Text |
id | pubmed-5861384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58613842018-03-22 Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial Adamson, Philip D Hunter, Amanda Williams, Michelle C Shah, Anoop S V McAllister, David A Pawade, Tania A Dweck, Marc R Mills, Nicholas L Berry, Colin Boon, Nicholas A Clark, Elizabeth Flather, Marcus Forbes, John McLean, Scott Roditi, Giles van Beek, Edwin J R Timmis, Adam D Newby, David E Heart Coronary Artery Disease OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4146 participants with suspected angina randomised to CTCA. Patients were dichotomised into NICE guideline-defined possible angina and non-anginal presentations. Primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and prognostic endpoint comprised fatal and non-fatal myocardial infarction (MI). RESULTS: In 3770 eligible participants, CTCA increased diagnostic certainty more in those with possible angina (relative risk (RR) 2.22 (95% CI 1.91 to 2.60), p<0.001) than those with non-anginal symptoms (RR 1.30 (1.11 to 1.53), p=0.002; p(interaction) <0.001). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (HR 0.32 (0.19 to 0.52), p<0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13 to 2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30 to 2.05), p=0.622). At 3.2 years of follow-up, fatal or non-fatal MI was reduced in patients with possible angina (3.2% to 1.9%%; HR 0.58 (0.34 to 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25 to 1.69), p=0.379). CONCLUSIONS: NICE-guided patient selection maximises the benefits of CTCA on diagnostic certainty, use of invasive coronary angiography and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA and increase the rates of invasive investigation. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT01149590;post results. BMJ Publishing Group 2018-02 2017-08-27 /pmc/articles/PMC5861384/ /pubmed/28844992 http://dx.doi.org/10.1136/heartjnl-2017-311508 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Coronary Artery Disease Adamson, Philip D Hunter, Amanda Williams, Michelle C Shah, Anoop S V McAllister, David A Pawade, Tania A Dweck, Marc R Mills, Nicholas L Berry, Colin Boon, Nicholas A Clark, Elizabeth Flather, Marcus Forbes, John McLean, Scott Roditi, Giles van Beek, Edwin J R Timmis, Adam D Newby, David E Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial |
title | Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial |
title_full | Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial |
title_fullStr | Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial |
title_full_unstemmed | Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial |
title_short | Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial |
title_sort | diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 national institute for health and care excellence guidance within a randomised trial |
topic | Coronary Artery Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861384/ https://www.ncbi.nlm.nih.gov/pubmed/28844992 http://dx.doi.org/10.1136/heartjnl-2017-311508 |
work_keys_str_mv | AT adamsonphilipd diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT hunteramanda diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT williamsmichellec diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT shahanoopsv diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT mcallisterdavida diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT pawadetaniaa diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT dweckmarcr diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT millsnicholasl diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT berrycolin diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT boonnicholasa diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT clarkelizabeth diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT flathermarcus diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT forbesjohn diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT mcleanscott diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT roditigiles diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT vanbeekedwinjr diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT timmisadamd diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial AT newbydavide diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial |